首页 | 本学科首页   官方微博 | 高级检索  
     

单病种付费对前列腺增生患者住院费用及医疗服务满意度的影响
引用本文:王芳,杜慈光,何春梅,张鸿萍,许丽英,陈立红,林夏鸿. 单病种付费对前列腺增生患者住院费用及医疗服务满意度的影响[J]. 中国校医, 2019, 33(9): 665
作者姓名:王芳  杜慈光  何春梅  张鸿萍  许丽英  陈立红  林夏鸿
作者单位:福建医科大学附属第二医院,福建 泉州 362001
摘    要:
目的 评估单病种付费对前列腺增生患者住院费用和医疗服务满意度的影响。方法 本院2015年6月—2018年6月主要诊断为前列腺增生的出院患者,按是否采用单病种付费将其分为实验组和对照组。采用典型抽样法,对2组患者进行医疗服务满意度问卷调查。比较分析2组患者住院费用、主要诊断符合率、治愈率、并发症发生率、治疗效果和医疗服务满意度评分。结果 采用单病种付费方式患者较未采用的患者住院时间有所缩短,治疗费用显著降低,其中化验费、检查费、药费和麻醉费减少明显,差异有统计学意义(P<0.01)。而2组主要诊断符合率、治愈率、并发症发生率和满意度评分差异无统计学意义(P>0.05)。结论 单病种付费在保障医疗安全和服务质量的基础上,明显降低了患者医疗费用,费用结构趋于合理,但也需要进一步完善相关配套政策,以更有效地发挥其作用。

关 键 词:住院  费用控制  前列腺增生  
收稿时间:2018-12-20

Effects of single-disease payment on hospitalization expenses and satisfactions of patients with benign prostatic hyperplasia
WANG Fang,DU Ci-guang,HE Chun-mei,ZHANG Hong-ping,XU Li-ying,CHEN Li-hong,LIN Xia-hong. Effects of single-disease payment on hospitalization expenses and satisfactions of patients with benign prostatic hyperplasia[J]. Chinese Journal of School Doctor, 2019, 33(9): 665
Authors:WANG Fang  DU Ci-guang  HE Chun-mei  ZHANG Hong-ping  XU Li-ying  CHEN Li-hong  LIN Xia-hong
Affiliation:Second Affiliated Hospital of Fujian Medical University, Quanzhou 362001, Fujian, China
Abstract:
Objective To evaluate the effects of the single-disease payment on the hospitalization expenses and satisfactions of patients with benign prostatic hyperplasia. Methods The medical records of discharged patients with benign prostatic hyperplasia from June 2015 to June 2018 were retrospectively analyzed in a tertiary grade A hospital in Fujian Province. The hospitalization expenses, hospital days, diagnosis accurate rate, cure rate, complications, and satisfactions of the patients were compared before and after the implementation of the single-disease payment. Results After the implementation of the single-disease payment, the total hospitalization expenses, drug, examination, inspection, and anesthesia expenses significantly declined (P<0.01), and the hospitalization time was significantly shorter (P<0.01). The diagnosis accurate rate, cure rate, complications, and satisfactions of the patents had no significant difference before and after the implementation of the single-disease payment (P>0.05). Conclusion The single-disease payment plays an important role in reducing the hospitalization expenses on the basis of ensuring medical safety and service satisfaction in the public hospital, and should be actively perfected and promoted.
Keywords:hospitalization    expense control    benign prostatic hyperplasia  
点击此处可从《中国校医》浏览原始摘要信息
点击此处可从《中国校医》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号